Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 8, Iss. 1, 2010-01 ,pp. : 55-75

Bentham Science Publishers

Access to resources Recommend Favorite

Anthracycline cardiotoxicity in long-term survivors of childhood cancer

By Scully Rebecca   Lipshultz Steven  

Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. : 122-128

Humana Press, Inc

Access to resources Recommend Favorite

Effect of aging on cardiac contractility in a rat model of chronic daunorubicin cardiotoxicity

By Cusack Barry   Young Stephan   Gambliel Hervé   Olson Richard  

Cardiovascular Toxicology, Vol. 2, Iss. 2, 2002-06 ,pp. : 99-109

Humana Press, Inc

Access to resources Recommend Favorite

Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory

By  

Current Cardiology Reviews, Vol. 8, Iss. 3, 2012-08 ,pp. : 209-214

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Remodeling as Therapeutic Target: Treating Heart Failure with Cardiac Support Devices

By Mann Douglas  

Heart Failure Reviews, Vol. 10, Iss. 2, 2005-06 ,pp. : 93-94

Springer Publishing Company

Access to resources Recommend Favorite